Ovral 28 500 _g / 50 _g Tablet
PDF Leaflet Revision Date: 21 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Fertility control and management of menstrual irregularities.
Dosage (summary)
One white tablet daily for 21 days, followed by one red tablet daily until finished.
Special Populations
- Caution in smokers over 35
- History of thromboembolic disorders
- Liver disease
Pregnancy & Breastfeeding
Contraindicated in pregnancy; may reduce milk production in lactating women.
Key Drug Interactions
- Antibiotics
- CYP3A4 inducers
- HCV treatments with ombitasvir/paritaprevir/ritonavir
Contraindications
- Hypersensitivity
- Thromboembolic disorders
- Uncontrolled hypertension
- Liver tumors
- Pregnancy
Common side effects
- Breakthrough bleeding
- Nausea
- Headache
- Breast tenderness
Counselling Points
- Take at the same time daily
- Use backup contraception if missed doses
- Report severe headaches or vision changes
Serious warnings
- Increased risk of thromboembolic events
- Serious cardiovascular risks in smokers
- Monitor for depression
Important Disclaimer
The Ovral 28 500 _g / 50 _g Tablet professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
